A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming
出版年份 2020 全文链接
标题
A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming
作者
关键词
-
出版物
Cancers
Volume 12, Issue 11, Pages 3396
出版商
MDPI AG
发表日期
2020-11-17
DOI
10.3390/cancers12113396
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
- (2020) T.K. Choueiri et al. ANNALS OF ONCOLOGY
- Methylation‐mediated miR‐214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN
- (2020) Hao Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS
- (2020) Min Jiao et al. BIOMEDICINE & PHARMACOTHERAPY
- Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets
- (2020) K. M. Taufiqul Arif et al. Cancers
- Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
- (2019) Benjamin Bian et al. OncoImmunology
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2
- (2019) Yoichi Osako et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MP16-13 SETD2-MEDIATED LOSS OF MIR-339 PROMOTES TUMOR PD-L1 EXPRESSION AND ATTENUATES ANTITUMOR IMMUNITY IN RENAL CELL CARCINOMA
- (2019) Haoran Liu et al. JOURNAL OF UROLOGY
- Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes
- (2019) Eleonora A. Braga et al. Frontiers in Genetics
- The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
- (2019) W. Marston Linehan et al. Nature Reviews Urology
- Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
- (2019) Lorena Incorvaia et al. ADVANCES IN THERAPY
- The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice
- (2019) Alessandra Raimondi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Changing Therapeutic Landscape of Metastatic Renal Cancer
- (2019) Javier C. Angulo et al. Cancers
- Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
- (2018) Giuseppe Badalamenti et al. CELLULAR IMMUNOLOGY
- Epigenetics in renal cell cancer: mechanisms and clinical applications
- (2018) Sophie C. Joosten et al. Nature Reviews Urology
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Key questions about the checkpoint blockade-are microRNAs an answer?
- (2018) Dragomir Mihnea et al. Cancer Biology & Medicine
- Monoclonal antibodies for the treatment of non-hematological tumors: a safety review
- (2018) Lidia Rita Corsini et al. Expert Opinion On Drug Safety
- Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives
- (2018) Panagiotis Tsiakanikas et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Role of miRNAs in Immune Responses and Immunotherapy in Cancer
- (2018) Maria Angelica Cortez et al. GENES CHROMOSOMES & CANCER
- Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
- (2018) Andrew Dhawan et al. Nature Communications
- MicroRNAs Associated with Von Hippel–Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review
- (2017) Lisa-Maria Schanza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-24-2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma
- (2017) Lu Jin et al. Molecular Medicine Reports
- Lysosome‑associated membrane protein 2 (LAMP‑2) expression induced by miR‑194‑5p downregulation contributes to sunitinib resistance in human renal cell carcinoma cells
- (2017) Tetsuya Yumioka et al. Oncology Letters
- Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin
- (2017) Sergio Rizzo et al. Oncotarget
- Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
- (2017) Francisca Dias et al. Oncotarget
- Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
- (2017) Rita de Cássia Oliveira et al. BMC Urology
- miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma
- (2017) LongJiao Ran et al. Biomed Research International
- HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
- (2016) Fabrizio Bronte et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells
- (2016) Falguni Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN
- (2016) WENXING FAN et al. Molecular Medicine Reports
- Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
- (2016) Daniele Fanale et al. Oncotarget
- Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma
- (2016) Lorena Incorvaia et al. Oncotarget
- Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus
- (2016) Daniela Cabibi et al. Oncotarget
- MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
- (2016) Roy Nofech-Mozes et al. Cancer Medicine
- Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression
- (2016) Saby George et al. JAMA Oncology
- A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome
- (2015) Bastian Fromm et al. Annual Review of Genetics
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma
- (2015) SHOULIN ZHANG et al. ONCOLOGY REPORTS
- miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W
- (2015) Kefeng Wang et al. TUMOR BIOLOGY
- Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
- (2014) Christian Rolfo et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
- (2013) H.W.Z. Khella et al. CARCINOGENESIS
- MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma
- (2012) Li Cui et al. BMC CANCER
- The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
- (2012) Lidia Rita Corsini et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Genetic and molecular characterization of the human Osteosarcoma 3AB-OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness
- (2012) Riccardo Di Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways
- (2012) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?
- (2012) S Caruso et al. Oncogenesis
- MicroRNA-708 Induces Apoptosis and Suppresses Tumorigenicity in Renal Cancer Cells
- (2011) S. Saini et al. CANCER RESEARCH
- KEGG for integration and interpretation of large-scale molecular data sets
- (2011) M. Kanehisa et al. NUCLEIC ACIDS RESEARCH
- miRBase: integrating microRNA annotation and deep-sequencing data
- (2010) A. Kozomara et al. NUCLEIC ACIDS RESEARCH
- miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics
- (2010) Nadav Bar et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started